0001561799-15-000001.txt : 20150312
0001561799-15-000001.hdr.sgml : 20150312
20150312091158
ACCESSION NUMBER: 0001561799-15-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150312
DATE AS OF CHANGE: 20150312
EFFECTIVENESS DATE: 20150312
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: eNeura, INC.
CENTRAL INDEX KEY: 0001561799
IRS NUMBER: 460990328
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-235727
FILM NUMBER: 15694558
BUSINESS ADDRESS:
STREET 1: 240 N. WOLFE RD.
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
BUSINESS PHONE: 4082456400
MAIL ADDRESS:
STREET 1: 240 N. WOLFE RD.
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
FORMER COMPANY:
FORMER CONFORMED NAME: eNeura, Inc.
DATE OF NAME CHANGE: 20140224
FORMER COMPANY:
FORMER CONFORMED NAME: eNeura Therapeutics LLC
DATE OF NAME CHANGE: 20130404
FORMER COMPANY:
FORMER CONFORMED NAME: Neuralieve, LLC
DATE OF NAME CHANGE: 20121107
D
1
primary_doc.xml
X0707
D
LIVE
0001561799
eNeura, INC.
801 W. Baltimore Street
Suite 502 L
Baltimore
MD
MARYLAND
21201
667.401.5580
DELAWARE
eNeura, Inc.
eNeura Therapeutics LLC
Neuralieve, LLC
Corporation
true
2012
David
Fischell
801 W. Baltimore Street
Suite 502 L
Baltimore
MD
MARYLAND
21201
Executive Officer
Director
Robert
Fischell
801 W. Baltimore Street
Suite 502 L
Baltimore
MD
MARYLAND
21201
Executive Officer
Director
Terry
Lierman
801 W. Baltimore Street
Suite 502 L
Baltimore
MD
MARYLAND
21201
Director
William
Kirwan
801 W. Baltimore Street
Suite 502 L
Baltimore
MD
MARYLAND
21201
Director
David
Rosen
801 W. Baltimore Street
Suite 502 L
Baltimore
MD
MARYLAND
21201
Executive Officer
Director
Eileen
O'Rourke
801 W. Baltimore Street
Suite 502 L
Baltimore
MD
MARYLAND
21201
Director
Michael
Finnegan
801 W. Baltimore Street
Suite 502 L
Baltimore
MD
MARYLAND
21201
Director
Other Technology
Decline to Disclose
- 06b
false
2015-03-04
false
true
true
false
0
15000000
15000000
0
false
1
0
0
500000
true
false
eNeura, INC.
David K. Rosen
David K. Rosen
CEO
2015-03-11